BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10754130)

  • 21. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
    J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus infection after organ transplantation: an update with special emphasis on renal transplantation.
    van Son WJ; The TH
    Transpl Int; 1989 Oct; 2(3):147-64. PubMed ID: 2553045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prospective study of cytomegalovirus infection in liver transplant recipients].
    Lumbreras C; Otero JR; Aguado JM; Lizasoaín M; Gómez R; García I; Fuertes A; Colina F; Moreno E; Noriega AR
    Med Clin (Barc); 1992 Oct; 99(11):401-5. PubMed ID: 1335102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.
    George MJ; Snydman DR; Werner BG; Griffith J; Falagas ME; Dougherty NN; Rubin RH
    Am J Med; 1997 Aug; 103(2):106-13. PubMed ID: 9274893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus infection after kidney transplantation and long-term graft loss.
    López-Oliva MO; Flores J; Madero R; Escuin F; Santana MJ; Bellón T; Selgas R; Jiménez C
    Nefrologia; 2017; 37(5):515-525. PubMed ID: 28946964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of mTOR inhibitors on the incidence of CMV infection in high-risk donor positive-recipient negative (D+/R-) kidney transplant recipients.
    Cristelli MP; Esmeraldo RM; Pinto CM; Sandes-Freitas TV; Felipe C; Lobo CF; Viana L; Mansur J; Stopa S; Santos DWC; Grenzi PC; Aguiar WF; Tedesco-Silva H; Pestana JOM
    Transpl Infect Dis; 2018 Aug; 20(4):e12907. PubMed ID: 29679515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors of cytomegalovirus infection after pediatric liver transplantation.
    Kawano Y; Mizuta K; Sanada Y; Urahashi T; Ihara Y; Okada N; Yamada N; Sasanuma H; Sakuma Y; Taniai N; Yoshida H; Kawarasaki H; Yasuda Y; Uchida E
    Transplant Proc; 2014 Dec; 46(10):3543-7. PubMed ID: 25498086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
    Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
    Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
    Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
    Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients.
    Bodro M; Sabé N; Lladó L; Baliellas C; Niubó J; Castellote J; Fabregat J; Rafecas A; Carratalà J
    Liver Transpl; 2012 Sep; 18(9):1093-9. PubMed ID: 22532316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus infection complicating renal transplantation and its relationship to acute transplant glomerulopathy.
    Boyce NW; Hayes K; Gee D; Holdsworth SR; Thomson NM; Scott D; Atkins RC
    Transplantation; 1988 Apr; 45(4):706-9. PubMed ID: 2833827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
    Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
    J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current review of cytomegalovirus in renal transplantation.
    Lopez-Rocafort L; Brennan DC
    Minerva Urol Nefrol; 2001 Sep; 53(3):145-58. PubMed ID: 11723440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
    Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
    Fallatah SM; Marquez MA; Bazerbachi F; Schiff JR; Cattral MS; McGilvray ID; Norgate A; Selzner M; Rotstein C; Husain S
    Clin Transplant; 2013; 27(4):503-9. PubMed ID: 23731387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CMV and BKV ureteritis: which prognosis for the renal graft?
    Fusaro F; Murer L; Busolo F; Rigamonti W; Zanon GF; Zacchello G
    J Nephrol; 2003; 16(4):591-4. PubMed ID: 14696764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors and impact of cytomegalovirus disease in simultaneous pancreas-kidney transplantation.
    Kaufman DB; Leventhal JR; Gallon LG; Parker MA; Koffron AJ; Fryer JP; Abecassis MM; Stuart FP
    Transplantation; 2001 Dec; 72(12):1940-5. PubMed ID: 11773893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of secondary cytomegalovirus prophylaxis for kidney and liver transplant recipients.
    Sullivan T; Brodginski A; Patel G; Huprikar S
    Transplantation; 2015 Apr; 99(4):855-9. PubMed ID: 25208322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and Risk Factors for Cytomegalovirus Infection in Patients With Kidney Transplantation: A Single-Center Experience.
    Feng S; Yang J; Wang W; Hu X; Liu H; Qian X; Feng D; Zhang X
    Transplant Proc; 2016 Oct; 48(8):2695-2699. PubMed ID: 27788803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.